SARS-CoV-2 Spike RBD Antibody
Igama lemveliso
I-HWTS-RT055A-Enzyme-Linked Immunosorbent Assay yokubona i-SARS-CoV-2 Spike RBD Antibody
Isatifikethi
CE
I-Epidemiology
Isifo seCoronavirus sika-2019 (COVID-19) yinyumoniya ebangelwa kukosuleleka yikoronavirus entsha ebizwa ngokuba yi-acute acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2).I-SARS-CoV-2 yayiluxinzelelo lwentsholongwane ye-beta-CoV efakwe iinxalenye ezingqukuva okanye eziyi-elliptical imilo emalunga ne-60nm-140nm.I-COVID-19 sisifo esosulelayo esinamandla sokuphefumla, kwaye uluntu lusesichengeni ngokubanzi.Umthombo owaziwayo ngoku wosulelo lwe-COVID-19 bosulelwe iimeko ze-COVID-19 kunye nabathwali be-SARS-CoV-2 abangenazimpawu.Inani labantu elitofelwe lugonyo lwe-SARS-CoV-2 lunokuvelisa i-spike RBD antibody okanye i-S antibody ye-SARS-CoV-2 ebonwa kwiserum kunye neplasma, enokuba njengesalathiso sokuvavanya ukusebenza kakuhle kwesitofu sokugonya se-SARS-CoV-2.
Iiparamitha zobuGcisa
| Ugcino | 2-8℃ |
| Beka ubomi kwishelufa | Iinyanga ezili-12 |
| Uhlobo loMfanekiso | i-serum yabantu, iplasma, iisampulu ezine-anticoagulant ye-EDTA, i-heparin sodium kunye ne-sodium citrate |
| CV | ≤15.0% |
| LoD | Ikhithi yaqinisekiswa ziimbekiselo zeLOD zomvelisi ngereyithi yesivumelwano 100%. |
| Ukuchaza ngokuthe ngqo | Izinto eziphazamisayo eziphakamileyo kwisampulu azichaphazeli ukusebenza kwekhithi yokubona i-SARS-CoV-2 spike RBD antibody.Izinto eziphazamisayo ezivavanyiweyo ziquka i-hemoglobin (500mg / dL), i-bilirubin (20mg / dL), i-triglyceride (1500 mg / dL), i-heterophil antibody (150U / mL), i-rheumatoid factor (100U / mL), i-10% (v / v) igazi lomntu, i-phenylephrine (2mg/mL), i-oxymetazoline (2mg/mL), i-sodium chloride (i-preservative ifakiwe) (20mg/mL), i-beclomethasone (20mg/mL), i-dexamethasone (20mg/mL), i-flunisolide (20μg/mL), Triamcinolone (2mg/mL), budesonide (2mg/mL), Mometasone (2mg/mL), fluticasone (2mg/mL), Histamine Dihydrochloride (5mg/mL), ainterferon (800IU/mL), zanamivir (20mg/mL), ribavirin (10mg/mL), oseltamivir (60ng/mL), Peramivir (1mg/mL) lopinavir (500mg/mL), ritonavir (1mg/mL), mupirocin (20mg/mL), azithromycin (1mg/mL), cefprozil ( 40μg / mL) kunye ne-meropenem (200mg / mL).Levofloxacin (10μg/mL), tobramycin (0.6mg/mL), EDTA (3mg/mL), iHeparin Sodium (25U/mL), kunye neSodium Citrate (12mg/mL) |
| Izixhobo Ezisebenzayo: | Umfundi we-microplate wendalo yonke kwi-wavelength 450nm/630nm. |
Ukuhamba komsebenzi
Ukhetho loku-1.
I-reagent yokutsalwa ecetyiswayo: Macro & Micro-Test Viral DNA/RNA Kit (HWTS-3001, HWTS-3004-32, HWTS-3004-48) kunye neMacro & Micro-Test Automatic Nucleic Acid Extractor (HWTS-3006).
Ukhetho lwesi-2.
I-Reagent yokutsalwa ecetyiswayo: I-Nucleic Acid Extraction okanye i-Reagent yokucoca (YDP302) yi-Tiangen Biotech(Beijing) Co.,Ltd.
